Catalyst Wire Dossier Catalyst Wire Dossier

Krytantek Ofteno PF

Krytantek Ofteno PF · Laboratorios Sophia S.A de C.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Krytantek Ofteno PF, covering 2023-12-12 to 2023-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension. [Phase 4]

See pricing